SEC Filing Details

Document Details

Filing Date
Jun 3, 2022
Document Date
Jun 3, 2022
Form Description
Written public communication by the subject company relating to a tender offer by a third party
Filing Group
Other
Company
Turning Point Therapeutics, Inc.
Issuer
Turning Point Therapeutics, Inc.

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb